Modified PCA regimen of remifentanil delivery for labour pain Prilagojeno od porodnice vodeno lajšanje porodne bolecine z remifentanilom

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-013803-70-SI

Enrollment

Registered

2009-10-02

Start date

2009-12-28

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy, labour, labour pain

Interventions

Trade Name: Ultiva Pharmaceutical Form: Powder for injection*

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age 18 - 35 years gestation 35 to 41 weeks ASA status I or II Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: emergency IUGR alergic reactions to opioids opioid addiction or abuse

Design outcomes

Primary

Measure	Time frame
Main Objective: study of a new remifentanil PCA regimen for labor pain - comparison of pain score, satisfaction, drug consumption, safety;Secondary Objective: pharmacodynamics;Primary end point(s): safety profile, pain relief, satisfaction	—

Countries

Slovenia

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026